Impact of thrombomodulin on mortality in hospitalized patients with COVID-19: A cohort-study
Conclusion: Patients with BDCA3 greater had higher mortality risk, it could be in response to worse inflammatory process.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Jimenez Gallardo, L. M., Sanchez-Santillan, R., Orea-Tejeda, A., Gonzalez-Islas, D., Montanez-Orozco, A., Rodriguez, A., Dominguez-Moya, D., Bautista-Galvan, G., Valderrabano-Salas, B., Carranza-Munoz, P., Hernandez-Lopez, N., Perez-Garcia, I., Jimenez-Va Tags: Clinical problems Source Type: research
More News: Bilirubin | Cardiology | Cardiovascular | COVID-19 | Heart | Infectious Diseases | Lovenox | Respiratory Medicine | SARS | Study | Thyroid